WAIT FOR SUGGESTIONS BY CATEGORY OR CONTINUE TYPING IN YOUR KEYWORDS
ENTER ONE OR MULTIPLE KEYWORDS & PRESS THE SEARCH BUTTON
Search
Favorites
Favorites
AdvancedMinimize
Clear
Prevalence of recurrent Extended-Spectrum Beta-Lactamase (ESBL) urinary tract infections (UTIs) in patients within a Urology service and introducing the concept of Faecal Microbiota Transplantation (FMT) as a treatment modality
BAUS ePoster online library. Gan C. 06/26/19; 259496; P13-2
Introduction Patients with an underlying urological diagnosis colonised with multidrug-resistant organisms (MDRO) such as ESBL are predisposed to recurrent UTIs. In FMT, healthy donor stool is administered into the GI tract to restore healthy gut microbiota. This is acknowledged as an effective treatment for recurrent Clostridium difficile infection, and now as an emerging method of eradicating MDROs. There are little data reporting on its therapeutic value in Urology.
METHODS
Retrospective analysis of culture positive urine isolates was obtained from 2015-2018 at a tertiary level service. Clinical profiles of patients with recurrent ESBL UTIs was performed. Four patients who had ESBL UTIs underwent FMT.
Results From June 2015-January 2018, 2059 patients under Urology services had a positive urine culture. 128 (6%) were ESBL. 456 patients had multiple positive urine cultures. Of these, 62 (14%) had multiple ESBL UTIs, constituting 8% of recurrent ESBL UTIs in the trust (806 total). 52/62 (84%) with recurrent ESBL UTIs had underlying urological diagnoses; 10/62 (16%) were purely managed for recurrent UTIs. 19/62 patients had >1 underlying diagnosis. 7/62 (11%) had urological reconstruction. 40/62 (65%) had prosthetic devices in situ (Table 1). Four patients received FMT, Table 2 describes their outcomes.
Conclusions ESBL UTIs are highly prevalent in Urology. Underlying causes should be investigated, due to high incidence of obstructive aetiologies. Our early experience of FMT for decolonisation and prevention of transition to infection with MDROs has shown FMT to be safe, well tolerated and effective.
Introduction Patients with an underlying urological diagnosis colonised with multidrug-resistant organisms (MDRO) such as ESBL are predisposed to recurrent UTIs. In FMT, healthy donor stool is administered into the GI tract to restore healthy gut microbiota. This is acknowledged as an effective treatment for recurrent Clostridium difficile infection, and now as an emerging method of eradicating MDROs. There are little data reporting on its therapeutic value in Urology.
METHODS
Retrospective analysis of culture positive urine isolates was obtained from 2015-2018 at a tertiary level service. Clinical profiles of patients with recurrent ESBL UTIs was performed. Four patients who had ESBL UTIs underwent FMT.
Results From June 2015-January 2018, 2059 patients under Urology services had a positive urine culture. 128 (6%) were ESBL. 456 patients had multiple positive urine cultures. Of these, 62 (14%) had multiple ESBL UTIs, constituting 8% of recurrent ESBL UTIs in the trust (806 total). 52/62 (84%) with recurrent ESBL UTIs had underlying urological diagnoses; 10/62 (16%) were purely managed for recurrent UTIs. 19/62 patients had >1 underlying diagnosis. 7/62 (11%) had urological reconstruction. 40/62 (65%) had prosthetic devices in situ (Table 1). Four patients received FMT, Table 2 describes their outcomes.
Conclusions ESBL UTIs are highly prevalent in Urology. Underlying causes should be investigated, due to high incidence of obstructive aetiologies. Our early experience of FMT for decolonisation and prevention of transition to infection with MDROs has shown FMT to be safe, well tolerated and effective.
{{ help_message }}
By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS). USER TERMS AND CONDITIONS | PRIVACY POLICY
Cookie Settings Accept Terms & all Cookies
Anonymous User Privacy Preferences
Strictly Necessary Cookies (Always Active)
MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.
Performance Cookies
Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.